Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Annals of Clinical and Translational Neurology
|
December 11, 2014
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types
Sarah Doss, Klaus-Peter Wandinger, Bradley T Hyman, et al.
Biorxiv : the Preprint Server for Biology
|
March 18, 2024
Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies
Sumaiya Nazeen, Xinyuan Wang, Dina Zielinski, et al.
Science Translational Medicine
|
August 17, 2018
Finding useful biomarkers for Parkinson's disease
Alice S Chen-Plotkin, Roger Albin, Roy Alcalay, et al.
Acta Neuropathologica
|
March 11, 2021
Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites
Jacqueline M Tokarew, Daniel N El-Kodsi, Nathalie A Lengacher, et al.
Nature Genetics
|
May 7, 2021
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease
Ganqiang Liu, Jiajie Peng, Zhixiang Liao, et al.
NPJ Parkinson'S Disease
|
May 14, 2026
Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts
Xiaoying Kang, Zechuan Lin, Fatma Zehra Calikusu, et al.
Neurology. Genetics
|
August 13, 2019
Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts
Hirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 11, 2019
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts
Hirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 1, 2020
Differences in the Presentation and Progression of Parkinson's Disease by Sex
Hirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Cerebellum (London, England)
|
December 1, 2022
Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotyping
Alain Ndayisaba, Ariana T Pitaro, Andrew S Willett, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Annals of Clinical and Translational Neurology
|
December 11, 2014
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types
Sarah Doss, Klaus-Peter Wandinger, Bradley T Hyman, et al.
Biorxiv : the Preprint Server for Biology
|
March 18, 2024
Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies
Sumaiya Nazeen, Xinyuan Wang, Dina Zielinski, et al.
Science Translational Medicine
|
August 17, 2018
Finding useful biomarkers for Parkinson's disease
Alice S Chen-Plotkin, Roger Albin, Roy Alcalay, et al.
Acta Neuropathologica
|
March 11, 2021
Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites
Jacqueline M Tokarew, Daniel N El-Kodsi, Nathalie A Lengacher, et al.
Nature Genetics
|
May 7, 2021
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease
Ganqiang Liu, Jiajie Peng, Zhixiang Liao, et al.
NPJ Parkinson'S Disease
|
May 14, 2026
Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts
Xiaoying Kang, Zechuan Lin, Fatma Zehra Calikusu, et al.
Neurology. Genetics
|
August 13, 2019
Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts
Hirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 11, 2019
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts
Hirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 1, 2020
Differences in the Presentation and Progression of Parkinson's Disease by Sex
Hirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Cerebellum (London, England)
|
December 1, 2022
Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotyping
Alain Ndayisaba, Ariana T Pitaro, Andrew S Willett, et al.
Page
of 14